Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart (Q44314806)

1 December 2017

title

Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart (English)

1 reference

1 December 2017

0 references

0 references

Jean-François Bouchard

series ordinal

1

1 reference

1 December 2017

Philippe Lépicier

series ordinal

2

1 reference

1 December 2017

Daniel Lamontagne

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

72

1 reference

1 December 2017

issue

16

1 reference

1 December 2017

page(s)

1859-1870

1 reference

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Coronary endothelial dysfunction after ischemia and reperfusion: a new therapeutic target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Ischemic preconditioning protects against coronary endothelial dysfunction induced by ischemia and reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Role of kinins in the endothelial protective effect of ischaemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Participation of prostaglandin E2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Delayed coronary endothelial protection 24 hours after preconditioning: role of free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Protective effects of preconditioning in cultured rat endothelial cells: effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Cannabinoid receptors and their endogenous agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Endocannabinoids: a new class of vasoactive substances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Endogenous cannabinoids mediate hypotension after experimental myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Protection afforded by preconditioning to the diabetic heart against ischaemic injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

5-Hydroxytryptamine mediates endothelium dependent coronary vasodilatation in the isolated rat heart by the release of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

In vitro activation of brain protein kinase C by the cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

Preconditioning of bovine endothelial cells. The protective effect is mediated by an adenosine A2 receptor through a protein kinase C signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2902474-8

10.1016/S0024-3205(02)02474-8

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference